The quarter beat a modest pre-release bar. Published estimates centered on roughly $1.04 billion of revenue and $1.12 of adjusted EPS; Donaldson delivered $1.059 billion and $1.15, respectively. That makes this a genuine but narrow earnings beat rather than a major upside surprise.
| Metric | Q4 FY2026 | Q4 FY2025 | Change | Market expectation |
|---|---|---|---|---|
| Net sales | $1,058.8M (Income Statement) | $980.7M | 8.0% | ~$1.04B |
| Adjusted diluted EPS | $1.15 (Non-GAAP EPS reconciliation) | $1.03 | 11.7% | ~$1.12 |
| GAAP diluted EPS | $1.10 (Income Statement) | $0.97 | 13.4% | — |
| Gross margin | 36.3% (Consolidated Rate Analysis) | 34.5% | +180 bps | — |
| Operating margin | 16.7% (Consolidated Rate Analysis) | 15.5% | +120 bps | — |
| Free cash flow | $185.2M (Non-GAAP financial measures) | $149.7M | 23.7% | — |
Margin execution was the stronger part of the result. Gross margin expanded to 36.3%, while operating margin reached 16.7%, showing that pricing, volume and mix more than offset higher operating expenses and acquisition-related costs. The filing says, “Gross margin was 36.3%, up 180 basis points from 34.5% in 2025 primarily due to higher volume, pricing and mix.” 〔0〕
Growth was broad, but the headline Industrial rebound overstates the underlying improvement. Mobile Solutions grew 7.9% and Life Sciences 9.7%, while Industrial Solutions rose 7.7%; however, Facet supplied 980 basis points of Industrial growth, and organic Aerospace and Defense sales declined 2.8% because of supply-chain constraints. The filing says, “Organic Aerospace and Defense sales declined 2.8% from prior year as a result of ongoing supply chain constraints.” 〔1〕
Fiscal 2027 guidance meets, rather than raises, the standing expectation. The company projects adjusted EPS of $4.22-$4.38, a midpoint of $4.30, matching the published FY2027 consensus midpoint of about $4.30. Sales growth of 5.5%-9.5% and an operating-margin range of 16.6%-17.2% frame another record year, but the outlook does not add a new upside leg beyond what investors were already assuming. The filing says, “Full-year EPS is forecast to be between $4.22 and $4.38, including approximately $0.12 of dilution from Facet.”
The net read is a narrow beat with a clean but not upgraded outlook. Q4 exceeded expectations on revenue, adjusted EPS and profitability, and cash generation improved. Against that, higher debt from the Facet acquisition lifted quarterly interest expense to $14.7 million from $7.1 million, while FY27 guidance simply lands at consensus. The balance is therefore mildly better than expected today, but not a clear change to the forward earnings framework.
Read the original 8-K on SEC EDGAR ↗